PD60 - PD60: Bladder Cancer: Invasive VI

Podium Presenter(s)

• AA

  Ahmet Aydin, MD
• 

  Siteng Chen

  PDF Slides and Audio
• 

  Francesco Claps, MD

  Resident
  University of Trieste

  PDF Slides and Audio
• 

  Christopher Dall, MD

  Medstar Georgetown University Hospital

  PDF Slides and Audio
• 

  Peter Hanna, MD,MS

  Urologist
  Urology Department- University of Minnesota

  PDF Slides and Audio
• 

  Sean Kern, MD

  Indiana University

  PDF Slides and Audio
• 

  Ronald Kool, MD

  McGill University

  PDF Slides and Audio
• 

  Seyedeh Sanam Ladi Seyedian, MD

  University of Southern California

  PDF Slides and Audio
• 

  Francesco Soria, MD

  Torino School of Medicine

  PDF Slides
• 

  Marshall Strother, MD

  Fox Chase Cancer Center

  PDF Slides and Audio
• HV

  Helena Vila Reyes, MD

  Columbia University - Irving Medical Center - NY Presbyterian Hospital

  PDF Slides and Audio
• NW

  Nathan C. Wong

Presentations:

• 7:00 AM – 9:00 AM

  PD60-01: Definitive radiation-based therapy for muscle-invasive bladder cancer: the Canadian multicenter experience
  Ronald Kool, MD
• 7:00 AM – 9:00 AM

  PD60-02: Longitudinal Health Related Quality of Life after Radical Cystectomy: Comparison of Ileal Conduit, Indiana Pouch, and Orthotopic Neobladder.
  Sean Kern, MD
• 7:00 AM – 9:00 AM

  PD60-03: Mutation in TP53 as Potential Marker of Clinical Benefit From PD-1/PD-L1Blockade Immunotherapy in Advanced Urothelial Carcinoma
  Siteng Chen – Shanghai Jiao Tong University School of Medicine
• 7:00 AM – 9:00 AM

  PD60-04: Survival analysis and predictors of non-muscle invasive bladder cancer recurrence in clinical complete-responders after neoadjuvant chemotherapy for muscle-invasive bladder cancer
  Helena Vila Reyes, MD
• 7:00 AM – 9:00 AM

  PD60-05: Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: results from a large multicenter cohort study
  Francesco Soria, MD – Torino School of Medicine
• 7:00 AM – 9:00 AM

  PD60-06: Practice patterns for extended VTE chemoprophylaxis among Urologic Oncologists
  Christopher P. Dall, MD
• 7:00 AM – 9:00 AM

  PD60-07: Acute kidney injury with enhanced recovery after surgery protocol in radical cystectomy surgery: a propensity score-matched study
  Peter Hanna, MD,MS – Peter
• 7:00 AM – 9:00 AM

  PD60-08: Oncological Outcomes Following Radical Cystectomy for Urothelial Carcinoma of the Bladder with Positive Lymph Nodes
  Seyedeh Sanam Ladi Seyedian, MD
• 7:00 AM – 9:00 AM

  PD60-09: Quantification of 5- and 30-day Ambulation after Radical Cystectomy
  Marshall C. Strother, MD
• 7:00 AM – 9:00 AM

  PD60-10: Impact of preoperative controlling nutritional status (CONUT) score on perioperative morbidity and survival outcomes in patients with bladder cancer treated with radical cystectomy: a multicenter analysis
  Francesco Claps, MD – Department of Urology, University of Trieste
• 7:00 AM – 9:00 AM

  PD60-11: PROGNOSTIC SIGNIFICANCE OF PERIVESICAL LYMPH NODE STATUS IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY
  Nathan C. Wong
• 7:00 AM – 9:00 AM

  PD60-12: Discretionary and Necessary Readmission After Radical Cystectomy
  Ahmet Murat Aydin, MD